INTRODUCTION
============

Spine fusion surgery using instruments is still a useful technique for treating degenerative spine disease or spine trauma. When performing instrument-applied spine surgery for degenerative diseases the complications associated with postoperative infection are problematic for both neurosurgeons and patients. The surgical wound infection rate varies with the type of surgery and other patient factors. For instance, the rate of infection is 0.7% for a simple intervertebral disc removal but between 3.2% and 4.2% for fusion using instruments[@b7-kjs-14-3-66],[@b10-kjs-14-3-66],[@b13-kjs-14-3-66]. Many laboratory tests are performed to deal with postoperative infection and enable early detection of infection. Measurement of serum C-reactive protein (CRP) levels and white blood cell (WBC) count are 2 basic blood exams used to identify potential infections after a surgical procedure. CRP is a useful parameter for detecting acute phase infection or systemic inflammatory response[@b4-kjs-14-3-66],[@b6-kjs-14-3-66],[@b8-kjs-14-3-66],[@b11-kjs-14-3-66]; however, monitoring changes in CRP values postoperatively is also useful for identifying a potential infection relapse or evaluating the effectiveness of treatment[@b1-kjs-14-3-66],[@b4-kjs-14-3-66]. Measurement of the natural CRP progression induced by a fusion operation is helpful for detection of postoperative infections. And there is the study showing that revision fusion cases have a higher rate of postoperative infection when compared to primary fusion cases[@b9-kjs-14-3-66]. These infections are generally related to the devascularization of previous wounds which can impede postoperative wound healing and may predispose the patient to wound infection[@b2-kjs-14-3-66]. Taking this into consideration, we supposed that the inflammatory response observed in revision spine surgery would be dissimilar from primary surgery cases. Since there was no data available for changes in CRP levels following a revision spine fusion operation, herein we investigated the natural course of changes in CRP and WBC count and compared these results with those obtained from the first operation group whether there are actual differences between the 2 groups.

MATERIALS AND METHODS
=====================

1. Patients
-----------

We reviewed 187 patients who underwent posterolateral fusion (PLF) at Pusan National University Yangsan Hospital from October 2013 to April 2015. Only single level fusion cases aimed to treat degenerative disease such as spondylolisthesis and spinal stenosis were enrolled. Fusion procedures intended to treat infection (n=22), cancer metastasis (n=8), hepatitis (n=12), trauma (n=37), postoperative hematoma (n=2), hematologic disorder (n=9), tumor (n=4), and postoperative infection (n=5) were excluded. Of the 88 patients enrolled, 67 patients were included in the primary lumbar PLF (pPLF) group and 21 were included in the revision PLF (rPLF) group. We carried out a retrospective assessment of preoperative and postoperative CRP levels and WBC count. Confounding factors such as body mass index (BMI), American Society of Anesthesiologists (ASA) physical status classification, arterial hypertension, diabetes mellitus, and perioperative antibiotics usage were recorded to evaluate their effects on CRP values and WBC count postoperatively. Postoperative infection cases (n=5) were recorded separately to compare CRP & WBC value courses with noninfectious cases. All patients agreed to written informed consent about complications of spinal fusion surgery

2. Surgical Procedures
----------------------

All operations were performed under general anesthesia. Perioperative antibiotics (cefazolin 1 g) was administered by intravenous injection within 1 hour of making the first skin incision and was continued every 8 hours for 3 days postoperatively in all enrolled cases. We did not observe any allergic reaction to this medication in our patient group.

The surgical procedure was performed using the PLF technique. After spinal canal decompression, 4 transpedicular screws (CD Horizon Legacy System; Medtronic, Minneapolis, MN, USA) were inserted under C-arm fluoroscope guidance. The autologous bone graft, hydroxyapatite and demineralized bone matrix were applied after the rods were firmly fixed to the screw.

3. Laboratory Tests
-------------------

All preoperative blood samples were acquired the day before surgery and additional postoperative specimens were taken on days 3, 6, and 9 after surgery at approximately the same time each day (7 AM). Serum CRP levels were quantified on an AU5800 analyzer using a high-sensitivity CRP method with heterogeneous immunoassay (Beckman Coulter's AU chemistry, Indianapolis, IN, USA). WBC count was calculated using the Sysmex HST N302 XE (Sysmex Corp., Tokyo, Japan). Normal CRP value was set to less than 0.5 mg/dL, and less than 12×10^9^/μL for normal WBC count

4. Statistics
-------------

Age, BMI, surgery time, peak values of the inflammatory parameters are given as mean values with the SD. The differences in confounding factors between the 2 procedures, with regards to CRP levels and WBC count, were evaluated using the Wilcoxon rank-sum test. Categorical values were offered in relative frequencies and the diversity between the groups was tested using the chi-square test or the Fisher exact test when the expected frequencies were less than 5. Kruskal-Walis test was performed to evaluate longitudinal differences in each group. To estimate the effect of the procedures on the peak values of CRP levels with adjustment for the potential confounding factors a multiple linear regression model was applied. Statistically significant factors (p\<0.05) were included in the model in the multivariate analyses in addition to the baseline values. All statistical analyses were performed using IBM SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA).

RESULTS
=======

1. Patients and CRP Kinetics
----------------------------

A total of 88 patients met the inclusion criteria and were included in the study. A summary of patient demographics, comorbidities and ASA physical status classification was shown in [Table 1](#t1-kjs-14-3-66){ref-type="table"}. The mean preoperative CRP levels for both surgical groups were within the normal range (0.18 \[SD, 0.30\] mg/dL, n=67, for the primary fusion group and 0.13 \[SD, 0.17\] mg/dL, n=21, for the revision group). A similar pattern of CRP response was observed in the postoperative period regardless of the procedure undertaken with peak values observed at postoperative day (POD) 3 ([Fig. 1](#f1-kjs-14-3-66){ref-type="fig"}). After pPLF operations, CRP values increased up to 4.17 (SD, 4.18) mg/dL, and showed statistically significant difference from preoperative CRP value (p=0.002). The increase observed following rPLF procedures was up to 4.88 (SD, 3.03) mg/dL, also demonstrates statistically significant difference from preoperative CRP value (p\<0.001). Both group's elevated CRP values did not show statistically significant differences between each other (p=0.24). After POD 3, CRP values for both primary and revision procedures decreased rapidly in all patients. At POD 6 the mean CRP was 1.59 (SD, 1.45) mg/dL after pPLF and 2.13 (SD, 2.03) mg/dL after rPLF. At POD 9 the mean CRP was 1.27 (SD, 2.66) mg/dL for pPLF patients and 0.86 (SD, 0.58) mg/dL for rPLF patients. Normalization days in pPLF was 9.68 (SD, 7.12) days, 10.61 (SD, 3.36) days for rPLF patients. There were no significant statistical differences between the 2 groups (p=0.26). Both pPLF and rPLF cases showed longitudinal difference in CRP values (p\<0.001, for both pPLF and rPLF) ([Table 2](#t2-kjs-14-3-66){ref-type="table"}).

2. WBC Count Kinetics
---------------------

The preoperative values for WBC count were similar and within the normal range for both patient groups (6.61\[SD, 1.78\]×10^9^/μL for pPLF, 6.67 \[SD, 2.41\]×10^9^/μL for rPLF). Both groups showed a peak level of WBC count at POD 3 ([Fig. 2](#f2-kjs-14-3-66){ref-type="fig"}) but there was no statistical significance between the 2 procedures. In primary cases, there is the longitudinal difference in WBC counts (p=0.046). But in cases of revision procedure, there is no statistically significant longitudinal differences (p=0.145) ([Table 2](#t2-kjs-14-3-66){ref-type="table"}).

3. Influence of Comorbidities and Surgery Time
----------------------------------------------

Using multiple regression analysis, we assessed whether there might be any correlation between peak CRP value and comorbidities ([Table 3](#t3-kjs-14-3-66){ref-type="table"}). Hypertension, coronary artery obstructive disease, and surgical duration had no influence on CRP kinetics postoperatively. ASA physical status classification was not found to affect peak postoperative CRP values. Diabetes mellitus did however have a statistically significant influence on peak CRP values (p=0.012) but obesity showed no relationship.

4. Course of Infection Patients' Cases
--------------------------------------

Details of CRP and WBC values of infection patients' cases are displayed in [Table 4](#t4-kjs-14-3-66){ref-type="table"}. Of our postoperative infection cases, 5 received antibiotics intended to treat a postoperative wound infection (primary operation, n=2; revision operation, n=3). Of these 5 cases, patient number 2 showed persistent CRP elevation, patient numbers 1, 3, 4, 5 displayed an interrupted decline, and all patients exhibited a prolonged period of normalization (\>20 days) ([Fig. 3](#f3-kjs-14-3-66){ref-type="fig"}). In WBC counts, primary operation-infection patients showed elevated WBC counts above normal range, while revision operation-infection patients' WBC counts were mostly within normal range ([Fig. 4](#f4-kjs-14-3-66){ref-type="fig"}).

DISCUSSION
==========

Herein we report that regardless of the procedure performed peak CRP levels are observed on POD 3 and are followed by a rapid decrease between POD 6 and 9 ([Fig. 1](#f1-kjs-14-3-66){ref-type="fig"}). Previous studies have also reported that the maximum CRP level appears on POD 2 and in the absence of any postoperative infection this elevation is followed by a rapid decline[@b1-kjs-14-3-66],[@b3-kjs-14-3-66],[@b6-kjs-14-3-66],[@b8-kjs-14-3-66]. Different types of surgery on different regions of the body parts result in different peak CRP values[@b6-kjs-14-3-66],[@b8-kjs-14-3-66]. This variation is believed to be caused by variation in iatrogenic tissue damage during surgery on different tissue types. Notably, in our study, the trend in postoperative CRP response showed no significant difference ([Table 1](#t1-kjs-14-3-66){ref-type="table"}, [Fig. 1](#f1-kjs-14-3-66){ref-type="fig"}). Mok et al.[@b5-kjs-14-3-66] reported that in noninfectious cases the changes observed in CRP levels following different surgical procedures appear to follow a similar pattern regardless of the operation or region. Comparison with infection cases, if the rapid decrease that we expect to see in CRP at POD 4--7 days is interrupted or values continue to rise, infectious complications should be considered[@b3-kjs-14-3-66],[@b4-kjs-14-3-66],[@b12-kjs-14-3-66].

In our study, we did not see any significant correlation between the observed changes in peak CRP level and patient medication, prior spinal surgery, or common comorbidities except for diabetes mellitus. Statistically significant difference was shown in the proportion of diabetic patients between the pPLF and rPLF patient groups ([Table 1](#t1-kjs-14-3-66){ref-type="table"}). Because WBC counts did not show significant longitudinal difference in rPLF, we conclude that CRP is a more sensitive parameter for the early detection of infectious complications than WBC count. A combination of erythrocyte sedimentation rate, body temperature, and CRP levels is useful for the interpretation of infectious complication in spinal fusion operations[@b11-kjs-14-3-66]. However, a large prospective randomized trial is necessary to confirm if serial monitoring of CRP is enough for early detection of infectious complications after spinal surgery.

CONCLUSION
==========

We found that CRP value course, CRP normalization days, peak CRP day and peak CRP values after spinal fusion surgery are similar regardless of primary or revision surgery. Because of this result, we recommend both the primary spinal fusion surgery and revision spinal fusion surgery should be monitored using CRP in similar way and the antibiotics administration should be determined.
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![Kinetics of postoperative C-reactive protein (CRP) levels (mg/dL); primary fusion operation (pPLF) vs. revision fusion operation (rPLF). Values are mean and standard error. Pre-OP, preoperation; POD, postoperative day.](kjs-14-3-66f1){#f1-kjs-14-3-66}

![Kinetics of postoperative white blood cell (WBC) counts (×10^9^/μL); primary fusion operation (pPLF) vs. revision fusion operation (rPLF). Values are mean and standard error. Pre-OP, preoperation; POD, postoperative day.](kjs-14-3-66f2){#f2-kjs-14-3-66}

![C-reactive protein (CRP) profiles of infection complication cases (mg/dL); infection patient (PT) numbers 1 and 2 had primary fusion surgery. Infection PT numbers 3, 4, and 5 had revision fusion surgery.](kjs-14-3-66f3){#f3-kjs-14-3-66}

![White blood cell (WBC) profiles of infection complication cases (×10^9^/μL); infection patient (PT) numbers 1 and 2 had primary fusion surgery. Infection PT numbers 3, 4, and 5 had revision fusion surgery.](kjs-14-3-66f4){#f4-kjs-14-3-66}

###### 

General patient characteristics (n=88), medical history, and comorbidities (n=88)

  Characteristic          pPLF (n=67)   rPLF (n=21)   p-value
  ----------------------- ------------- ------------- ---------------------------------------------------
  Age (yr)                58.58±11.11   63.48±12.19   0.597
  Male sex                21 (31.3)     7 (33.3)      0.864
  BMI ≥25 kg/m^2^         36 (53.7)     15 (71.4)     0.152
  Operation time (hr)     4.94±1.09     5.19±1.17     0.597
  Comorbidities                                       
   Diabetes mellitus      10 (14.9)     8 (38.1)      0.022[\*](#tfn4-kjs-14-3-66){ref-type="table-fn"}
   Hypertension           30 (44.8)     10 (47.6)     0.819
   CAOD                   2 (3.0)       4 (19.0)      0.027[\*](#tfn4-kjs-14-3-66){ref-type="table-fn"}
  ASA PS classification                               
   I                      33 (49.3)     11 (52.4)     0.803
   II                     31 (46.3)     10 (47.6)     0.914
   III                    3 (4.5)       0 (0)         1.000
   IV                     0 (0)         0 (0)         NA
   V                      0 (0)         0 (0)         NA

Values are presented as mean±standard deviation or number (%).

pPLF, primary posterolateral fusion cases; rPLF, revision posterolateral fusion cases; BMI, body mass index; NA, not applicable; CAOD, coronary artery obstructive disease; ASA PS, American Society of Anesthesiologists physical status.

The p-values are means from chi-square, Fisher exact tests or Wilcoxon rank-sum tests

p\<0.05, statistically significant difference.

###### 

Mean values of preoperative and postoperative CRP and leukocyte profiles

  Variable                                              pPLF (n=67)   rPLF (n=21)   p-value[†](#tfn8-kjs-14-3-66){ref-type="table-fn"}
  ----------------------------------------------------- ------------- ------------- ----------------------------------------------------
  CRP (mg/dL)                                                                       
   Preoperative                                         0.18±0.30     0.13±0.17     0.501
   Day 3                                                4.17±4.18     4.88±3.03     0.242
   Day 6                                                1.59±1.45     2.13±2.03     0.250
   Day 9                                                1.27±2.66     0.86±0.58     0.419
   Normalization days                                   9.68±7.12     10.61±3.36    0.260
   p-value[‡](#tfn9-kjs-14-3-66){ref-type="table-fn"}   \<0.001       \<0.001       
  WBC (×10^9^/μL)                                                                   
   Preoperative                                         6.61±1.78     6.67±2.41     0.663
   Day 3                                                9.31±3.47     8.37±2.88     0.384
   Day 6                                                8.73±3.58     6.97±2.11     0.081
   Day 9                                                7.99±3.72     7.00±2.63     0.279
   p-value[‡](#tfn9-kjs-14-3-66){ref-type="table-fn"}   0.046         0.145         

Values are presented as mean±standard deviation.

pPLF, primary posterolateral fusion cases; rPLF, revision posterolateral fusion cases; CRP, C-reactive protein; WBC, white blood cell.

Normal CRP value: \<0.5 mg/dL; Normal WBC value: \<12×10^9^/μL

The p-values were derived from Wilcoxon rank-sum tests.

Longitudinal differences were obtained by using Kuruskal-Wallis test.

###### 

Multiple regression analysis of peak values of CRP profiles for all patients

  Variable                β       p-value
  ----------------------- ------- ----------------------------------------------------
  Diabetes mellitus       0.27    0.012[\*](#tfn12-kjs-14-3-66){ref-type="table-fn"}
  Operation time          0.02    0.843
  Body mass index         0.15    0.166
  Age                     0.12    0.246
  Sex                     −0.14   0.198
  Hypertention            0.14    0.186
  CAOD                    0.16    0.138
  ASA PS classification   −0.11   0.370

Multifactorial linear regression models were used to find out which factor is reliable to peak CRP value.

CRP, C-reactive protein; CAOD, coronary artery obstructive disease; β; Standardized regression coefficient; ASA PS, American Society of Anesthesiologists physical status.

p\<0.05, statistically significant difference.

###### 

CRP and WBC course of infection complications

  Variable              Patient number                          
  --------------------- ---------------- ------- ------- ------ ------
  CRP (mg/dL)                                                   
   Preoperative         0.15             0.29    0.03    0.05   0.12
   Day 3                7.52             0.59    2.30    2.81   0.27
   Day 6                1.24             2.77    0.03    1.66   0.05
   Day 9                2.78             6.57    1.13    5.35   1.05
   Normalization days   30               60      25      55     22
  WBC(×10^9^/μL)                                                
   Preoperative         9.87             11.40   5.50    7.64   4.53
   Day 3                19.39            13.21   12.24   6.80   9.35
   Day 6                14.89            17.13   7.32    7.87   8.25
   Day 9                17.75            14.27   6.39    7.77   8.37

CRP, C-reactive protein; WBC, white blood cell; pPLF, primary posterolateral fusion cases; rPLF, revision posterolateral fusion cases.

Normal CRP value: \<0.5 mg/dL; Normal WBC value: \<12×10^9^/μL
